94 related articles for article (PubMed ID: 11251179)
1. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers.
Takakura S; Kohno T; Manda R; Okamoto A; Tanaka T; Yokota J
Int J Oncol; 2001 Apr; 18(4):817-24. PubMed ID: 11251179
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the PPP1R3 gene in human cancer.
Kohno T; Takakura S; Yamada T; Okamoto A; Tanaka T; Yokota J
Cancer Res; 1999 Sep; 59(17):4170-4. PubMed ID: 10485448
[TBL] [Abstract][Full Text] [Related]
3. Somatic mutations and genetic polymorphisms of the PPP1R3 gene in patients with several types of cancers.
Takakura S; Kohno T; Shimizu K; Ohwada S; Okamoto A; Yokota J
Oncogene; 2000 Feb; 19(6):836-40. PubMed ID: 10698503
[TBL] [Abstract][Full Text] [Related]
4. Alterations of the PPP1R3 gene in hematological malignancies.
Inoue K; Kohno T; Takakura S; Morishita K; Takita J; Hayashi Y; Mizoguchi H; Yokota J
Int J Oncol; 2000 Oct; 17(4):717-21. PubMed ID: 10995882
[TBL] [Abstract][Full Text] [Related]
5. Low frequency of alterations of the alpha (PPP2R1A) and beta (PPP2R1B) isoforms of the subunit A of the serine-threonine phosphatase 2A in human neoplasms.
Calin GA; di Iasio MG; Caprini E; Vorechovsky I; Natali PG; Sozzi G; Croce CM; Barbanti-Brodano G; Russo G; Negrini M
Oncogene; 2000 Feb; 19(9):1191-5. PubMed ID: 10713707
[TBL] [Abstract][Full Text] [Related]
6. Activation of synovial fibroblasts in rheumatoid arthritis: lack of Expression of the tumour suppressor PTEN at sites of invasive growth and destruction.
Pap T; Franz JK; Hummel KM; Jeisy E; Gay R; Gay S
Arthritis Res; 2000; 2(1):59-64. PubMed ID: 11219390
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genetic and epigenetic alterations of the PTEN gene in gastric cancer.
Sato K; Tamura G; Tsuchiya T; Endoh Y; Sakata K; Motoyama T; Usuba O; Kimura W; Terashima M; Nishizuka S; Zou T; Meltzer SJ
Virchows Arch; 2002 Feb; 440(2):160-165. PubMed ID: 11964046
[TBL] [Abstract][Full Text] [Related]
8. PPP1R3 gene (protein phosphatase 1) alterations in colorectal cancer and its relationship to metastasis.
Hayashida Y; Goi T; Hirono Y; Katayama K; Urano T; Yamaguchi A
Oncol Rep; 2005 Jun; 13(6):1223-7. PubMed ID: 15870946
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the PPP2R1B gene located at 11q23 in human colorectal cancers.
Takagi Y; Futamura M; Yamaguchi K; Aoki S; Takahashi T; Saji S
Gut; 2000 Aug; 47(2):268-71. PubMed ID: 10896920
[TBL] [Abstract][Full Text] [Related]
10. Alterations of the PPP2R1B gene in human lung and colon cancer.
Wang SS; Esplin ED; Li JL; Huang L; Gazdar A; Minna J; Evans GA
Science; 1998 Oct; 282(5387):284-7. PubMed ID: 9765152
[TBL] [Abstract][Full Text] [Related]
11. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas.
Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS
Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913
[TBL] [Abstract][Full Text] [Related]
12. Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM.
Chen YH; Hansen L; Chen MX; Bjørbaek C; Vestergaard H; Hansen T; Cohen PT; Pedersen O
Diabetes; 1994 Oct; 43(10):1234-41. PubMed ID: 7926294
[TBL] [Abstract][Full Text] [Related]
13. PPP2R1B gene alterations inhibit interaction of PP2A-Abeta and PP2A-C proteins in colorectal cancers.
Tamaki M; Goi T; Hirono Y; Katayama K; Yamaguchi A
Oncol Rep; 2004 Mar; 11(3):655-9. PubMed ID: 14767517
[TBL] [Abstract][Full Text] [Related]
14. Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines.
Hsu LC; Huang X; Seasholtz S; Potter DM; Gollin SM
Oncogene; 2006 Sep; 25(40):5517-26. PubMed ID: 16619035
[TBL] [Abstract][Full Text] [Related]
15. Absence of p51 alteration in human ovarian cancer.
Shinozaki H; Okamoto A; Shimizu K; Saito M; Yokota J; Ochiai K
Int J Oncol; 2001 Mar; 18(3):549-52. PubMed ID: 11179485
[TBL] [Abstract][Full Text] [Related]
16. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
Unoki M; Nakamura Y
Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
[TBL] [Abstract][Full Text] [Related]
17. The protein phosphatase 2A subunit Bgamma gene is identified to be differentially expressed in malignant melanomas by subtractive suppression hybridization.
Deichmann M; Polychronidis M; Wacker J; Thome M; Näher H
Melanoma Res; 2001 Dec; 11(6):577-85. PubMed ID: 11725204
[TBL] [Abstract][Full Text] [Related]
18. Alterations of PTEN/MMAC1, a candidate tumor suppressor gene, and its homologue, PTH2, in small cell lung cancer cell lines.
Kim SK; Su LK; Oh Y; Kemp BL; Hong WK; Mao L
Oncogene; 1998 Jan; 16(1):89-93. PubMed ID: 9467947
[TBL] [Abstract][Full Text] [Related]
19. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
[TBL] [Abstract][Full Text] [Related]
20. Absence of PPP2R1A mutations in Wilms tumor.
Ruteshouser EC; Ashworth LK; Huff V
Oncogene; 2001 Apr; 20(16):2050-4. PubMed ID: 11360189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
